Home | News & Events | IDEA News | Anti-rejection drug used in organ transplants protects patients from Alzheimer's

Anti-rejection drug used in organ transplants protects patients from Alzheimer's

Individuals who underwent organ transplant are given a treatment to prevent the body from rejecting the transplanted organ.

Now, findings of a new study conducted by researchers from the University of Texas Medical Branch at Galveston suggest that the drug could also provide protection against Alzheimer's disease.

Read more on the Tech Times website.